These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8701702)

  • 21. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current antimicrobial usage for the management of neutropenic fever in Korea: a nationwide survey.
    Choi SM; Park SH; Lee DG; Choi JH; Yoo JH; Shin WS
    J Korean Med Sci; 2008 Dec; 23(6):941-7. PubMed ID: 19119433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.
    Bosi A; Laszlo D; Bacci S; Fanci R; Guidi S; Saccardi R; Vannucchi AM; Rossi-Ferrini P
    J Chemother; 1999 Aug; 11(4):287-92. PubMed ID: 10465131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration of granulocyte colony-stimulating factor from day 7 after autologous bone marrow transplantation: effects on neutropenia and duration of hospitalization.
    Moreau P; Le Tortorec S; Mahé B; Legros L; Milpied N; Harousseau JL
    Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):455-8. PubMed ID: 7538659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.
    Serody JS; Berrey MM; Albritton K; O'Brien SM; Capel EP; Bigelow SH; Weber DJ; Gabriel ; Wiley JM; Schell MJ; Gilligan PH; Shea TC
    Bone Marrow Transplant; 2000 Sep; 26(5):533-8. PubMed ID: 11019843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced requirement for antibiotic therapy targeting gram-negative organisms in febrile, neutropenic patients with cancer who are receiving antibacterial chemoprophylaxis with oral quinolones.
    Bow EJ; Loewen R; Vaughan D
    Clin Infect Dis; 1995 Apr; 20(4):907-12. PubMed ID: 7795093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue.
    Meisenberg B; Gollard R; Brehm T; McMillan R; Miller W
    Support Care Cancer; 1996 Sep; 4(5):364-9. PubMed ID: 8883230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts.
    Wimperis JZ; Baglin TP; Marcus RE; Warren RE
    Bone Marrow Transplant; 1991 Nov; 8(5):363-7. PubMed ID: 1768971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutropenic enterocolitis after high-dose chemotherapy and autologous stem cell transplantation: incidence, risk factors, and outcome.
    Gil L; Poplawski D; Mol A; Nowicki A; Schneider A; Komarnicki M
    Transpl Infect Dis; 2013 Feb; 15(1):1-7. PubMed ID: 22862907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
    Sobecks RM; Le Beau MM; Anastasi J; Williams SF
    Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
    Kim JH; Goulston C; Zangari M; Tricot G; Boyer MW; Hanson KE
    Transpl Infect Dis; 2014 Jun; 16(3):421-9. PubMed ID: 24797543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
    Gomez-Martin C; Solá C; Hornedo J; Perea S; Lumbreras C; Valentí V; Arcediano A; Rodriguez M; Salazar R; Cortés-Funes H; Hidalgo M
    J Clin Oncol; 2000 May; 18(10):2126-34. PubMed ID: 10811678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas].
    Gorin NC; Coiffier B; Hayat M; Fouillard L; Kuentz M; Flesch M; Colombat P; Boivin P; Slavin S; Lemarié JC
    Presse Med; 1993 Jan; 22(3):109-20. PubMed ID: 8493215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital.
    Griffin TC; Buchanan GR
    J Pediatr; 1992 Jul; 121(1):28-33. PubMed ID: 1625089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral antibiotics for non-Hodgkin's lymphoma patients with low risk neutropenic fever--a comparative controlled study].
    Shacham-Abulafia A; Elis A; Manor Y; Lishner M
    Harefuah; 2010 Jun; 149(6):344-8, 405. PubMed ID: 20941921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
    Slavin MA; Grigg AP; Schwarer AP; Szer J; Spencer A; Sainani A; Thursky KA; Roberts AW
    Bone Marrow Transplant; 2007 Jul; 40(2):157-63. PubMed ID: 17468774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation.
    Schnabel B; Schmidmaier R; Franke D; Emmerich B; Straka C
    Cytotherapy; 2006; 8(5):473-9. PubMed ID: 17050252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Majolino I; Pearce R; Taghipour G; Goldstone AH
    J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of intravenous antibiotics at the onset of neutropenia in patients receiving outpatient-based hematopoietic stem cell transplants.
    Hamadah A; Schreiber Y; Toye B; McDiarmid S; Huebsch L; Bredeson C; Tay J
    PLoS One; 2012; 7(9):e46220. PubMed ID: 23029441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.